UCB CEO and leadership

Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, President of the Board of the European Federation of Pharmaceutical Associations (EFPIA), a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world. His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”. As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents

Vivendi's deputy Chief Financial Officer since May 2004, Sandrine Dufour also became the group’s Executive Vice President, Innovation in October 2010. Before joining Vivendi in 1999, she was a financial analyst at BNP and then at stockbrokers CAI Cheuvreux, specialized in the telecom industry. Sandrine Dufour is a graduate of ESSEC business school. She holds certificates from the SFAF (the French society of financial analysts) and the CFA (Chartered Financial Analyst). She’s a member of the Board of Directors of PagesJaunes.

As a Head of Neurology Solutions and a member of UCB's Executive Committee, I manage the global development and commercialization of innovative solutions that create value for people living with neurological disorders, such as epilepsy, neuroinflammation and neuro-degenerative conditions. I am also in charge of UCB's corporate activities in Europe and International markets.

Prior to joining UCB, I have held various positions across the full Health Care Value Chain, including Business Development and Licensing, Manufacturing, Marketing and Sales, and Research & Clinical Development.

Prof. Dr. med. Iris Loew-Friedrich is Executive Vice-President Biopharma Development Solutions and Chief Medical Officer, UCB S.A.. She provides strategic global leadership for project leadership, world-wide clinical development, medical affairs and global regulatory affairs for UCB’s portfolio of pipeline projects and products. The mission of Biopharma Development Solutions is to develop patient solutions with proven superior and sustainable value for patients suffering from severe diseases. Dr. Loew-Friedrich also oversees UCB’s Patient Affairs function, which places a strategic focus on better understanding and improving the patient experience in currently underserved medical areas in immunological and neurological diseases. Prior to taking on her current role in March 2008, Dr. Loew-Friedrich was UCB’s Global Head of Development, during which time she oversaw clinical development of key neurology and immunology products. From 2001 to 2009, Dr. Loew-Friedrich also served as the head of Global Research and Development for Schwarz Pharma, which UCB moved to acquire in 2006.She was also on the Schwarz Pharma Executive Board. Dr. Loew-Friedrich held several medical and R&D roles, including Vice- President and Head of Global Projects at BASF Pharma, Ludwigshafen, Germany; Vice-President, Head of Global Clinical Management, HMR/Aventis, and Therapeutic Area Head Rheumatology and Bone Diseases, Hoechst/HMR, Bridgewater, New Jersey. Dr. Loew-Friedrich received her medical license and her PhD from Frankfurt University, Frankfurt, Germany, in 1985. From 1985 to 1992, Dr. Loew- Friedrich was the staff physician at the Department for Internal Medicine at the Frankfurt University Medical School, with sub-specialties in immunology, nephrology, and transplantation medicine. She is board-certified in internal medicine and holds a professorship at Frankfurt University Medical School.

Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President. He is a member of the Board of Directors of UCB, President of the Board of the European Federation of Pharmaceutical Associations (EFPIA), a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences). Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world. His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years. For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”. As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents